Search

Search Constraints

You searched for: Author/Creator Richard, Corentin

Search Results

1. 42: A Competing Risk Analysis of Prognostic Factors for Local and Regional Recurrence and Survival Outcomes in Early-Stage Non-Small Cell Lung Cancer Treated with Stereotactic Ablative Radiation Therapy. (September 2022)

2. 679 High fiber diet modifies gut microbiome, propionate production, intratumor immune response and is associated with outcome in patients with lung cancer treated with immune checkpoint inhibitors. (9th November 2020)

3. 679 High fiber diet modifies gut microbiome, propionate production, intratumor immune response and is associated with outcome in patients with lung cancer treated with immune checkpoint inhibitors. (9th November 2020)

4. An exceptional metaplastic lobular breast carcinoma diagnosed through exome sequencing. Issue 9 (24th January 2020)

5. Angiotensin-converting enzyme (ACE) inhibitor prescription affects non-small-cell lung cancer (NSCLC) patients response to PD-1/PD-L1 immune checkpoint blockers. (1st January 2020)

6. Antibiotics are associated with decreased progression-free survival of advanced melanoma patients treated with immune checkpoint inhibitors. (3rd April 2019)

7. CD4 T cell-intrinsic STING signaling controls the differentiation and effector functions of TH1 and TH9 cells. Issue 1 (28th January 2022)

8. Circulating β-d-Glucan as a Marker of Subclinical Coronary Plaque in Antiretroviral Therapy-Treated People With Human Immunodeficiency Virus. (7th March 2021)

9. Durvalumab therapy following chemoradiation compared with a historical cohort treated with chemoradiation alone in patients with stage III non–small cell lung cancer: A real-world multicentre study. (January 2021)

10. Efficacy of immune checkpoint inhibitors in older patients with non-small cell lung cancer: Real-world data from multicentric cohorts in Canada and France. Issue 5 (June 2020)